Similar Posts

  • Aurora Burlington’s Alpha-1 Antitrypsin Phenotype Testing Priced at $195

    Alpha-1 Antitrypsin Phenotype Testing is a specialized genetic laboratory test aimed at identifying specific variations in the alpha-1 antitrypsin protein. This test is crucial for diagnosing Alpha-1 Antitrypsin Deficiency, a hereditary condition that can cause serious lung and liver diseases. The $195 fee at Aurora Medical Center Burlington includes the laboratory analysis and interpretation of…

  • Aurora Burlington Prices: Myelogram Thoracic Study and Interpretation Is $2,400.00

    A Myelogram Thoracic Study and Interpretation is a specialized diagnostic procedure used to assess issues within the thoracic (mid-back) region of the spine. It is particularly valuable for identifying spinal cord problems, herniated discs, or abnormalities that standard X-rays or MRIs may miss. At Aurora Burlington, the $2,400 fee includes both the myelogram procedure itself…

  • Inpatient Hemodialysis Priced at $1,950 at Aurora Burlington, WI

    Inpatient Hemodialysis: Clinical Context, Cost Components, and Tips Inpatient hemodialysis is a critical hospital-based treatment for patients with acute or chronic kidney failure who require immediate, closely monitored care that cannot be managed in an outpatient setting. At Aurora Medical Center Burlington, this service is priced at $1,950 and encompasses the use of specialized dialysis…

  • Aurora Burlington Price for Bilateral Sacral Augmentation: $5,790.00

    Bilateral Sacral Augmentation is a surgical procedure designed to enhance or stabilize the sacral region at the base of the spine, often performed to address sacral insufficiency fractures or provide structural support due to weakness in this area. At Aurora Medical Center Burlington, the all-inclusive fee for this procedure is $5,790.00. This cost covers essential…

  • Aurora Burlington’s Fetal Fibronectin Test Priced at $620

    The Fetal Fibronectin Test at Aurora Medical Center Burlington is a non-invasive diagnostic procedure priced at $620, used to evaluate the risk of preterm birth in pregnant individuals between 22 and 34 weeks gestation. By detecting fetal fibronectin in vaginal secretions—a protein serving as a marker for potential preterm labor—this test helps clinicians decide on…